Tadahiro Nambu

5.4k total citations · 2 hit papers
23 papers, 3.8k citations indexed

About

Tadahiro Nambu is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Cognitive Neuroscience. According to data from OpenAlex, Tadahiro Nambu has authored 23 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Endocrine and Autonomic Systems and 8 papers in Cognitive Neuroscience. Recurrent topics in Tadahiro Nambu's work include Regulation of Appetite and Obesity (8 papers), Sleep and Wakefulness Research (8 papers) and Sleep and related disorders (5 papers). Tadahiro Nambu is often cited by papers focused on Regulation of Appetite and Obesity (8 papers), Sleep and Wakefulness Research (8 papers) and Sleep and related disorders (5 papers). Tadahiro Nambu collaborates with scholars based in Japan, United States and Norway. Tadahiro Nambu's co-authors include Takeshi Sakurai, Katsutoshi Goto, Masashi Yanagisawa, Yasuhiko Hosoya, Katsuyoshi Mizukami, Ken-ichi Yagami, Junko Hara, Carsten T. Beuckmann, Fumihiro Sugiyama and Christopher M. Sinton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Tadahiro Nambu

23 papers receiving 3.7k citations

Hit Papers

Genetic Ablation of Orexin Neurons in Mice Results in Nar... 1999 2026 2008 2017 2001 1999 250 500 750 1000

Peers

Tadahiro Nambu
F S Bartlett United States
A. Jackie Hunter United Kingdom
Andrei B. Belousov United States
Shibani Mukherjee United States
Fabienne de Bilbao Switzerland
Tadahiro Nambu
Citations per year, relative to Tadahiro Nambu Tadahiro Nambu (= 1×) peers Vigdis T. Gautvik

Countries citing papers authored by Tadahiro Nambu

Since Specialization
Citations

This map shows the geographic impact of Tadahiro Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadahiro Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadahiro Nambu more than expected).

Fields of papers citing papers by Tadahiro Nambu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadahiro Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadahiro Nambu. The network helps show where Tadahiro Nambu may publish in the future.

Co-authorship network of co-authors of Tadahiro Nambu

This figure shows the co-authorship network connecting the top 25 collaborators of Tadahiro Nambu. A scholar is included among the top collaborators of Tadahiro Nambu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadahiro Nambu. Tadahiro Nambu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwai, Kenichi, Tadahiro Nambu, Yukie Kashima, et al.. (2021). A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery. Science Advances. 7(21). 19 indexed citations
2.
Yashiro, Hiroaki, Kazunobu Aoyama, Tadahiro Nambu, et al.. (2020). Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. PLoS ONE. 15(1). e0228212–e0228212. 26 indexed citations
3.
Iwai, Kenichi, Tadahiro Nambu, Jie Yu, et al.. (2019). Abstract A093: Potential combination partners for a novel CDC7-selective Inhibitor, TAK-931. Molecular Cancer Therapeutics. 18(12_Supplement). A093–A093. 1 indexed citations
4.
Hirayama, Takaharu, Masanori Okaniwa, Hiroshi Banno, et al.. (2016). Design and synthesis of fused bicyclic inhibitors targeting the L5 loop site of centromere-associated protein E. Bioorganic & Medicinal Chemistry Letters. 26(17). 4296–4300. 2 indexed citations
5.
Ohashi, Akihiro, Momoko Ohori, Kenichi Iwai, et al.. (2015). A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity. PLoS ONE. 10(12). e0144675–e0144675. 26 indexed citations
6.
Ohashi, Akihiro, Momoko Ohori, Kenichi Iwai, et al.. (2015). Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells. Nature Communications. 6(1). 7668–7668. 132 indexed citations
7.
Nambu, Hirohide, Hirohiko Hikichi, Norihiro Nagano, et al.. (2011). Characterization of metabolic phenotypes of mice lacking GPR61, an orphan G-protein coupled receptor. Life Sciences. 89(21-22). 765–772. 19 indexed citations
8.
Shimomura, Toshiyasu, Yoko Nakatsuru, Takashi Mita, et al.. (2010). MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel. Molecular Cancer Therapeutics. 9(1). 157–166. 100 indexed citations
9.
Sakai, Takumi, et al.. (2009). Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis. Biochemical and Biophysical Research Communications. 384(2). 173–179. 17 indexed citations
10.
Nambu, Tadahiro, Hitoshi Nishizawa, Masanori Iwaki, et al.. (2004). Intectin, a Novel Small Intestine-specific Glycosylphosphatidylinositol-anchored Protein, Accelerates Apoptosis of Intestinal Epithelial Cells. Journal of Biological Chemistry. 279(41). 42867–42874. 19 indexed citations
11.
Inoue, Shinichi, Tadahiro Nambu, & Toshiyasu Shimomura. (2004). The RAIG Family Member, GPRC5D, Is Associated with Hard-Keratinized Structures. Journal of Investigative Dermatology. 122(3). 565–573. 85 indexed citations
12.
Muroya, Shinji, Hisayuki Funahashi, Akihiro Yamanaka, et al.. (2004). Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose‐responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. European Journal of Neuroscience. 19(6). 1524–1534. 192 indexed citations
13.
Hara, Junko, Carsten T. Beuckmann, Tadahiro Nambu, et al.. (2001). Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity. Neuron. 30(2). 345–354. 1092 indexed citations breakdown →
14.
Yamanaka, Akihiro, Kaiko Kunii, Tadahiro Nambu, et al.. (2000). Orexin-induced food intake involves neuropeptide Y pathway. Brain Research. 859(2). 404–409. 206 indexed citations
15.
Nakamura, Toshiaki, Kazuhide Uramura, Tadahiro Nambu, et al.. (2000). Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system11Published on the World Wide Web on 27 June 2000.. Brain Research. 873(1). 181–187. 274 indexed citations
16.
Moriguchi, Takashi, Takeshi Sakurai, Tadahiro Nambu, Masashi Yanagisawa, & Katsutoshi Goto. (1999). Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neuroscience Letters. 264(1-3). 101–104. 229 indexed citations
17.
Shibahara, Megumi, Takeshi Sakurai, Tadahiro Nambu, et al.. (1999). Structure, tissue distribution, and pharmacological characterization of Xenopus orexins. Peptides. 20(10). 1169–1176. 86 indexed citations
18.
Kunii, Kaiko, Akihiro Yamanaka, Tadahiro Nambu, et al.. (1999). Orexins/hypocretins regulate drinking behaviour1Published on the World Wide Web on 4 August 1999.1. Brain Research. 842(1). 256–261. 176 indexed citations
19.
Nambu, Tadahiro, Takeshi Sakurai, Katsuyoshi Mizukami, et al.. (1999). Distribution of orexin neurons in the adult rat brain. Brain Research. 827(1-2). 243–260. 911 indexed citations breakdown →
20.
Nambu, Tadahiro, et al.. (1979). [Inflammatory fibroid polyp of the stomach--a histological study of 40 cases (author's transl)].. PubMed. 70(12). 721–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026